{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T21:16:32Z","timestamp":1772572592948,"version":"3.50.1"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2020,3,10]],"date-time":"2020-03-10T00:00:00Z","timestamp":1583798400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,3,10]],"date-time":"2020-03-10T00:00:00Z","timestamp":1583798400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"crossref","award":["JP26460446"],"award-info":[{"award-number":["JP26460446"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"crossref","award":["JP17K17894"],"award-info":[{"award-number":["JP17K17894"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["15ck0106015h0002"],"award-info":[{"award-number":["15ck0106015h0002"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1007\/s00277-020-03967-x","type":"journal-article","created":{"date-parts":[[2020,3,10]],"date-time":"2020-03-10T12:02:52Z","timestamp":1583841772000},"page":"1093-1098","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Comprehensive immunohistochemical analysis of immune checkpoint molecules in adult T cell leukemia\/lymphoma"],"prefix":"10.1007","volume":"99","author":[{"given":"Mai","family":"Takeuchi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2356-3725","authenticated-orcid":false,"given":"Hiroaki","family":"Miyoshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazutaka","family":"Nakashima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keisuke","family":"Kawamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyohei","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eriko","family":"Yanagida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroko","family":"Muta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mayuko","family":"Moritsubo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Umeno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takaharu","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masao","family":"Seto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichi","family":"Ohshima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,3,10]]},"reference":[{"key":"3967_CR1","unstructured":"Ohshima K, Jaffe E, Yoshino T, Siebert R (2017) Adult T-cell leukemia\/lymphoma. In: Swerdlow SH, campo CE, Harris NL, et al., editors. World Health Organization classification of tumours. Revised 4th edn. IARC press, Lyon, pp 363\u2013367"},{"key":"3967_CR2","doi-asserted-by":"publisher","unstructured":"Shimoyama M (1991) Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia\u2013lymphoma. A report from the lymphoma study group (1984\u201387). Br J Haematol 79:428\u2013437. https:\/\/doi.org\/10.1111\/j.1365-2141.1991.tb08051.x","DOI":"10.1111\/j.1365-2141.1991.tb08051.x"},{"key":"3967_CR3","doi-asserted-by":"publisher","unstructured":"Miyoshi H, Kiyasu J, Kato T, Yoshida N, Shimono J, Yokoyama S, Taniguchi H, Sasaki Y, Kurita D, Kawamoto K, Kato K, Imaizumi Y, Seto M, Ohshima K (2016) PD-L1 expression on neoplastic or stromal cells is respectively a poor or good prognostic factor for adult T-cell leukemia\/lymphoma. Blood 128:1374\u20131381. https:\/\/doi.org\/10.1182\/blood-2016-02-698936","DOI":"10.1182\/blood-2016-02-698936"},{"key":"3967_CR4","doi-asserted-by":"publisher","unstructured":"Hodi FS, O\u2019Day SJ, McDermott DF et al (2010) Improved survival with ipilimumab in patients with metastatic melanoma. N Engl J Med 363:711\u2013723. https:\/\/doi.org\/10.1056\/NEJMoa1003466","DOI":"10.1056\/NEJMoa1003466"},{"key":"3967_CR5","doi-asserted-by":"publisher","unstructured":"Pennnock GK, Chow LQM (2015) The evolving role of immune checkpoint inhibitors in cancer treatment. Oncologist 20:812\u2013822. https:\/\/doi.org\/10.1634\/theoncologist.2014-0422","DOI":"10.1634\/theoncologist.2014-0422"},{"key":"3967_CR6","doi-asserted-by":"publisher","unstructured":"Aspeslagh S, Postel-Vinay S, Rusakiewicz S, Soria JC, Zitvogel L, Marabelle A (2016) Rationale for anti-OX40 cancer immunotherapy. Eur J Cancer 52:50\u201366. https:\/\/doi.org\/10.1016\/j.ejca.2015.08.021","DOI":"10.1016\/j.ejca.2015.08.021"},{"key":"3967_CR7","doi-asserted-by":"publisher","unstructured":"Croft M, So T, Soroosh P (2009) The significance of OX40 and OX40L to T-cell biology and immune disease. Immunol Rev 229:173\u2013191. https:\/\/doi.org\/10.1111\/j.1600-065x.2009.00766.x","DOI":"10.1111\/j.1600-065x.2009.00766.x"},{"key":"3967_CR8","doi-asserted-by":"publisher","unstructured":"Liu K, Ye H, Zhou J et al (2018) OX40 regulates the conversion and suppressive function of double-negative regulatory T-cells. Int Immunopharmacol 65:16\u201322. https:\/\/doi.org\/10.1016\/j.intimp.2018.09.035","DOI":"10.1016\/j.intimp.2018.09.035"},{"key":"3967_CR9","doi-asserted-by":"publisher","unstructured":"Omar HA, Tolba MF (2019) Tackling molecular targets beyond PD-1\/PD-L1: novel approaches to boost patient\u2019s response to cancer immunotherapy. Crit Rev Oncol Hematol 135:21\u201329. https:\/\/doi.org\/10.1016\/j.critrevonc.2019.01.009","DOI":"10.1016\/j.critrevonc.2019.01.009"},{"key":"3967_CR10","doi-asserted-by":"publisher","unstructured":"Chou FC, Chen HY, Kuo CC et al (2018) Role of galectins in tumors and in clinical immunotherapy. Int J Mol Sci 19:E430. https:\/\/doi.org\/10.3390\/ijms19020430","DOI":"10.3390\/ijms19020430"},{"key":"3967_CR11","doi-asserted-by":"publisher","unstructured":"Anderson AC, Joller N, Kuchroo VK (2016) Lag-3, Tim-3, and TIGIT: co-inhibitory receptors with specialized functions in immune regulation. Immunity. 44:989\u20131004. https:\/\/doi.org\/10.1016\/j.immuni.2016.05.001","DOI":"10.1016\/j.immuni.2016.05.001"},{"key":"3967_CR12","doi-asserted-by":"publisher","unstructured":"Anderson AC (2012) Tim-3, a negative regulator of anti-tumor immunity. Curr Opin Immunol 24:213\u2013216. https:\/\/doi.org\/10.1016\/j.coi.2011.12.005","DOI":"10.1016\/j.coi.2011.12.005"},{"key":"3967_CR13","doi-asserted-by":"publisher","unstructured":"Das M, Zhu C, Kuchroo VK (2017) Tim-3 and its role in regulating anti-tumor immunity. Immunol Rev 276:97\u2013111. https:\/\/doi.org\/10.1111\/imr.12520","DOI":"10.1111\/imr.12520"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-020-03967-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-020-03967-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-020-03967-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,10]],"date-time":"2021-03-10T00:22:42Z","timestamp":1615335762000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-020-03967-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,10]]},"references-count":13,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["3967"],"URL":"https:\/\/doi.org\/10.1007\/s00277-020-03967-x","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,10]]},"assertion":[{"value":"11 December 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 February 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee (include name of committee + reference number) and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}